BLACK FRIDAY 23–30 November: every kit at our 50+ kit price, any quantity. See the offer →
BLACK FRIDAY 23–30 November: every kit at our 50+ kit price, any quantity. See the offer →
BLACK FRIDAY 23–30 November: every kit at our 50+ kit price, any quantity. See the offer →
BLACK FRIDAY 23–30 November: every kit at our 50+ kit price, any quantity. See the offer →
Factory-direct means the kit is dispatched from the production site that synthesised, lyophilized and lot-coded it, rather than from an intermediary’s stock. For a reseller it removes one layer of handling, storage and margin between the batch record and the parcel.
With an intermediary, the kit you receive may have been bought in bulk, stored for an unknown period, and re-labelled. The lot number on the vial may or may not correspond to a record the intermediary can produce. Factory-direct supply keeps one chain: batch produced, vials lot-coded, kit dispatched, record available against the lot number.
Ask for the batch record against a lot number from the kit you received. A factory-direct supplier can return the batch’s status (report issued, or testing in progress) for that exact lot. An intermediary often cannot, or sends a certificate that does not quote your lot number. Ask also where the parcel ships from and whether the dispatch window is stated; Notary Peptides dispatches within 3 business days.
Not automatically. It means the price you pay includes one fewer margin, and that the documentation you receive was generated by the party that made the product. Whether a particular factory-direct quote is lower than an intermediary’s depends on the tier and the compound.
That production runs on pharmaceutical-grade lines in China and Southeast Asia with batch records for every run, and that kits ship factory-direct with tracking. Site-level details are shared with qualified partners at the due-diligence stage; see the facility page.
Most research peptide brands in Western markets do not synthesise anything: bulk material is commonly produced in Asia, bought by brands, and re-vialed or re-labelled domestically. Nothing is wrong with that model when the documentation chain survives it — but each handoff is a place where the lot record can detach from the product. Factory-direct supply is the collapsed version of the same chain: the site that synthesised and lyophilized the batch is the site that lot-coded the vials and dispatched the kit, so the record and the product have never been separated. The buyer’s question is therefore not “domestic or imported” — much of it is imported either way — but “how many hands between the batch record and my parcel”.
A domestic reseller shipping from local stock delivers in days; factory-direct from Asia takes 3–15 days of tracked transit plus the dispatch window. What the extra transit buys is the unbroken chain and one fewer margin in the price. For a research buyer restocking on a planned cycle, the transit difference is absorbed by ordering earlier; for a reseller, it argues for holding a small local buffer of fast movers while replenishing factory-direct. The tradeoff only bites when buying is unplanned — which is itself the more expensive habit.
At Notary Peptides, kits are produced on partner pharmaceutical production lines and dispatched from production, with batch records kept for every run.
Transit is 3–15 days by region, tracked; see the shipping guide.
Site-level information is shared with qualified partners at due diligence.
Not automatically. It removes one margin from the chain; whether a given quote beats an intermediary’s depends on the compound and the tier.
All Notary Peptides products are chemical reference materials supplied strictly for in-vitro laboratory research. Not for human or veterinary use. This guide describes commercial terms and documentation only.